These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6342683

  • 1. Degradation of the four monoiodoinsulin isomers by the insulin protease of rat liver.
    Brush JS, Sonne O, Gliemann J.
    Biochim Biophys Acta; 1983 Jun 09; 757(3):269-73. PubMed ID: 6342683
    [Abstract] [Full Text] [Related]

  • 2. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
    Ryan MP, Peavy DE, Frank BH, Duckworth WC.
    Endocrinology; 1984 Aug 09; 115(2):591-9. PubMed ID: 6378594
    [Abstract] [Full Text] [Related]

  • 3. Degradation products of insulin generated by hepatocytes and by insulin protease.
    Duckworth WC, Hamel FG, Peavy DE, Liepnieks JJ, Ryan MP, Hermodson MA, Frank BH.
    J Biol Chem; 1988 Feb 05; 263(4):1826-33. PubMed ID: 3276679
    [Abstract] [Full Text] [Related]

  • 4. High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease.
    Hamel FG, Peavy DE, Ryan MP, Duckworth WC.
    Endocrinology; 1986 Jan 05; 118(1):328-33. PubMed ID: 3510119
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Receptor-mediated degradation of insulin in isolated rat adipocytes. Formation of a degradation product slightly smaller than insulin.
    Sonne O.
    Biochim Biophys Acta; 1987 Jan 19; 927(1):106-11. PubMed ID: 3539208
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of insulin intermediates and sites of cleavage of native insulin by insulin protease from human fibroblasts.
    Stentz FB, Kitabchi AE, Schilling JW, Schronk LR, Seyer JM.
    J Biol Chem; 1989 Dec 05; 264(34):20275-82. PubMed ID: 2684974
    [Abstract] [Full Text] [Related]

  • 10. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O, Linde S, Larsen TR, Gliemann J.
    Hoppe Seylers Z Physiol Chem; 1983 Feb 05; 364(2):101-10. PubMed ID: 6341199
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
    Yaso S.
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr 20; 64(4):289-302. PubMed ID: 3042472
    [Abstract] [Full Text] [Related]

  • 16. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
    Misbin RI, Almira EC.
    Diabetes; 1989 Feb 20; 38(2):152-8. PubMed ID: 2644137
    [Abstract] [Full Text] [Related]

  • 17. Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme.
    Roth RA, Mesirow ML, Yokono K, Baba S.
    Endocr Res; 1984 Feb 20; 10(2):101-12. PubMed ID: 6389104
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.